297 related articles for article (PubMed ID: 9779854)
1. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.
Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME
J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159
[TBL] [Abstract][Full Text] [Related]
4. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic significance of antinuclear antibodies].
Swaak AJ
Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
[TBL] [Abstract][Full Text] [Related]
7. The clinical utility of a positive antinuclear antibody test result.
Abeles AM; Abeles M
Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of immuno-serological laboratory data].
Kasukawa R; Tojo J; Kuwana T; Obara K
Rinsho Byori; 1996 Dec; 44(12):1157-63. PubMed ID: 8990934
[TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibody testing. A study of clinical utility.
Slater CA; Davis RB; Shmerling RH
Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
Sokka T; Pincus T
J Rheumatol; 2009 Jul; 36(7):1387-90. PubMed ID: 19411389
[TBL] [Abstract][Full Text] [Related]
11. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
Chopra A; Anuradha V; Edmonds J
J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
[TBL] [Abstract][Full Text] [Related]
12. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
[TBL] [Abstract][Full Text] [Related]
14. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting.
Narain S; Richards HB; Satoh M; Sarmiento M; Davidson R; Shuster J; Sobel E; Hahn P; Reeves WH
Arch Intern Med; 2004 Dec 13-27; 164(22):2435-41. PubMed ID: 15596633
[TBL] [Abstract][Full Text] [Related]
16. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation.
Moder KG; Wener MH; Weisman MH; Ishimori ML; Wallace DJ; Buckeridge DL; Homburger HA
J Rheumatol; 2007 May; 34(5):978-86. PubMed ID: 17407218
[TBL] [Abstract][Full Text] [Related]
17. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
Williams HJ; Alarcon GS; Joks R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; St Clair EW; Willkens RF; Yarboro C; Morgan JG; Egger MJ; Ward JR
J Rheumatol; 1999 Apr; 26(4):816-25. PubMed ID: 10229402
[TBL] [Abstract][Full Text] [Related]
18. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
[TBL] [Abstract][Full Text] [Related]
19. How useful is the rheumatoid factor? An analysis of sensitivity, specificity, and predictive value.
Shmerling RH; Delbanco TL
Arch Intern Med; 1992 Dec; 152(12):2417-20. PubMed ID: 1456851
[TBL] [Abstract][Full Text] [Related]
20. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
